WBB Securities analyst Stephen Brozak came out today with a favorable report on Caladrius Biosciences Inc (NASDAQ:CLBS), after the company announced Tuesday that it has signed …
In a research report released today, WBB Securities analyst Stephen Brozak reiterated a Buy rating on shares of Sarepta Therapeutics Inc (NASDAQ:SRPT), and raised …
Celldex Therapeutics, Inc. (NASDAQ:CLDX) price target has been raised by research analyst Stephen Brozak at WBB Securities.
Sarepta Therapeutics Inc (NASDAQ:SRPT) price target has been raised by research analyst Stephen Brozak at WBB Securities. The new price target now stands …